Recent Advances in Green Metallic Nanoparticles for Enhanced Drug Delivery in Photodynamic Therapy: A Therapeutic Approach

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Mar 11

PMID 36902238

Authors

Alexander Chota

Blassan P George

Heidi Abrahamse

Affiliations

Soon will be listed here.

Abstract

Globally, cancer is one of the leading causes of death among men and women, it is characterized by the unregulated proliferation of tumor cells. Some of the common risk factors associated with cancer development include the consistent exposure of body cells to carcinogenic agents such as alcohol, tobacco, toxins, gamma rays and alpha particles. Besides the above-mentioned risk factors, conventional therapies such as radiotherapy, and chemotherapy have also been linked to the development of cancer. Over the past decade, tremendous efforts have been invested in the synthesis of eco-friendly green metallic nanoparticles (NPs), and their medical application. Comparatively, metallic NPs have greater advantages over conventional therapies. Additionally, metallic NPs can be functionalized with different targeting moieties e.g., liposomes, antibodies, folic acid, transferrin, and carbohydrates. Herein, we review and discuss the synthesis, and therapeutic potential of green synthesized metallic NPs for enhanced cancer photodynamic therapy (PDT). Finally, the advantages of green hybridized activatable NPs over conventional photosensitizers (PSs) and the future perspectives of nanotechnology in cancer research are discussed in the review. Furthermore, we anticipate that the insights offered in this review will inspire the design and development of green nano-formulations for enhanced image-guided PDT in cancer treatment.

Citing Articles

Application of liposomal nanoparticles of berberine in photodynamic therapy of A549 lung cancer spheroids.

Moloudi K, Abrahamse H, George B Biochem Biophys Rep. 2024; 40:101877.

PMID: 39634336 PMC: 11615602. DOI: 10.1016/j.bbrep.2024.101877.

Recent Advances in Photodynamic Therapy: Metal-Based Nanoparticles as Tools to Improve Cancer Therapy.

Mariano S, Carata E, Calcagnile L, Panzarini E Pharmaceutics. 2024; 16(7).

PMID: 39065629 PMC: 11280090. DOI: 10.3390/pharmaceutics16070932.

Targeting triple negative breast cancer stem cells using nanocarriers.

Dasari N, Guntuku G, Pindiprolu S Discov Nano. 2024; 19(1):41.

PMID: 38453756 PMC: 10920615. DOI: 10.1186/s11671-024-03985-y.

Recent Innovations of Mesoporous Silica Nanoparticles Combined with Photodynamic Therapy for Improving Cancer Treatment.

Nady D, Hassan A, Amin M, Bakowsky U, Fahmy S Pharmaceutics. 2024; 16(1).

PMID: 38276492 PMC: 10821275. DOI: 10.3390/pharmaceutics16010014.

Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review.

Roshani M, Rezaian-Isfahni A, Lotfalizadeh M, Khassafi N, Jafari Najaf Abadi M, Nejati M Cancer Cell Int. 2023; 23(1):280.

PMID: 37981671 PMC: 10657605. DOI: 10.1186/s12935-023-03115-1.

References

Ramos T, Villacis-Aguirre C, Lopez-Aguilar K, Santiago Padilla L, Altamirano C, Toledo J . The Hitchhiker's Guide to Human Therapeutic Nanoparticle Development. Pharmaceutics. 2022; 14(2). PMC: 8879439. DOI: 10.3390/pharmaceutics14020247. View

Rengan A, Bukhari A, Pradhan A, Malhotra R, Banerjee R, Srivastava R . In vivo analysis of biodegradable liposome gold nanoparticles as efficient agents for photothermal therapy of cancer. Nano Lett. 2015; 15(2):842-8. DOI: 10.1021/nl5045378. View

Dymek M, Sikora E . Liposomes as biocompatible and smart delivery systems - the current state. Adv Colloid Interface Sci. 2022; 309:102757. DOI: 10.1016/j.cis.2022.102757. View

Wang L, Xu J, Yan Y, Liu H, Karunakaran T, Li F . Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1). Artif Cells Nanomed Biotechnol. 2019; 47(1):1617-1627. DOI: 10.1080/21691401.2019.1594862. View

Lee N, Ko W, Hsueh P . Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms. Front Pharmacol. 2019; 10:1153. PMC: 6787836. DOI: 10.3389/fphar.2019.01153. View

Weinstain R, Slanina T, Kand D, Klan P . Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials. Chem Rev. 2020; 120(24):13135-13272. PMC: 7833475. DOI: 10.1021/acs.chemrev.0c00663. View

Guan J, Shen Q, Zhang Z, Jiang Z, Yang Y, Lou M . Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption. Nat Commun. 2018; 9(1):2982. PMC: 6065320. DOI: 10.1038/s41467-018-05384-1. View

Nguyen H, Park J, Kang S, Kim M . Surface plasmon resonance: a versatile technique for biosensor applications. Sensors (Basel). 2015; 15(5):10481-510. PMC: 4481982. DOI: 10.3390/s150510481. View

Brentnall M, Rodriguez-Menocal L, De Guevara R, Cepero E, Boise L . Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013; 14:32. PMC: 3710246. DOI: 10.1186/1471-2121-14-32. View

10.

Jeevanandam J, Barhoum A, Chan Y, Dufresne A, Danquah M . Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018; 9:1050-1074. PMC: 5905289. DOI: 10.3762/bjnano.9.98. View

11.

Perez-Jimenez A, Lyu D, Lu Z, Liu G, Ren B . Surface-enhanced Raman spectroscopy: benefits, trade-offs and future developments. Chem Sci. 2021; 11(18):4563-4577. PMC: 8159237. DOI: 10.1039/d0sc00809e. View

12.

Liu J, Li R, Yang B . Carbon Dots: A New Type of Carbon-Based Nanomaterial with Wide Applications. ACS Cent Sci. 2020; 6(12):2179-2195. PMC: 7760469. DOI: 10.1021/acscentsci.0c01306. View

13.

Al-Khafaji M, Gaal A, Wacha A, Bota A, Varga Z . Particle Size Distribution of Bimodal Silica Nanoparticles: A Comparison of Different Measurement Techniques. Materials (Basel). 2020; 13(14). PMC: 7412153. DOI: 10.3390/ma13143101. View

14.

Carrington E, Zhan Y, Brady J, Zhang J, Sutherland R, Anstee N . Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ. 2017; 24(5):878-888. PMC: 5423112. DOI: 10.1038/cdd.2017.30. View

15.

Aniogo E, George B, Abrahamse H . Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation. Molecules. 2020; 25(22). PMC: 7696921. DOI: 10.3390/molecules25225308. View

16.

Westphal D, Kluck R, Dewson G . Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2013; 21(2):196-205. PMC: 3890949. DOI: 10.1038/cdd.2013.139. View

17.

Villaverde G, Baeza A . Targeting strategies for improving the efficacy of nanomedicine in oncology. Beilstein J Nanotechnol. 2019; 10:168-181. PMC: 6350877. DOI: 10.3762/bjnano.10.16. View

18.

Abdelatty A, Ahmed M, Abdel-Kareem M, Dmerdash M, Mady R, Saad A . Acute and Delayed Doxorubicin-Induced Myocardiotoxicity Associated with Elevation of Cardiac Biomarkers, Depletion of Cellular Antioxidant Enzymes, and Several Histopathological and Ultrastructural Changes. Life (Basel). 2021; 11(9). PMC: 8467687. DOI: 10.3390/life11090880. View

19.

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y . Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020; 7:193. PMC: 7468194. DOI: 10.3389/fmolb.2020.00193. View

20.

Taymaz-Nikerel H, Karabekmez M, Eraslan S, Kirdar B . Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells. Sci Rep. 2018; 8(1):13672. PMC: 6135803. DOI: 10.1038/s41598-018-31939-9. View